The transformative potential of AI-driven CRISPR-Cas9 genome editing to enhance CAR T-cell therapy
- 10 September 2024
- journal article
- review article
- Published by Elsevier in Computers in Biology and Medicine
- Vol. 182, 109137
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Improving chimeric antigen receptor T-cell therapies by using artificial intelligence and internet of things technologies: A narrative reviewEuropean Journal of Pharmacology, 2024
- A versatile CRISPR-Cas13d platform for multiplexed transcriptomic regulation and metabolic engineering in primary human T cellsCell, 2024
- Recent advances and current challenges in CAR-T cell therapyBiotechnology Letters, 2023
- A Novel CRISPR-MultiTargeter Multi-agent Reinforcement learning (CMT-MARL) algorithm to identify editable target regions using a Hybrid scoring from multiple similar sequencesApplied Intelligence, 2022
- Genome-wide detection and analysis of CRISPR-Cas off-targets2021
- Machine learning applications in systems metabolic engineeringCurrent Opinion in Biotechnology, 2020
- A new collection of real world applications of fractional calculus in science and engineeringCommunications in Nonlinear Science and Numerical Simulation, 2018
- Toxicity and management in CAR T-cell therapyMolecular Therapy-Oncolytics, 2016
- Reversal of Tumor Immune Inhibition Using a Chimeric Cytokine ReceptorMolecular Therapy, 2014
- Transcription activator‐like effector nucleases (TALENs): A highly efficient and versatile tool for genome editingBiotechnology and Bioengineering, 2013